Stockreport
Alcoholic Hepatitis Treatment Market To Reach USD 4.9 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Fort Collins, Colorado, May 09, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of alcohol-related liver diseases drives the demand for alcoholic hepatitis treatment in the forecast period. The alcoholic hepatitis treatment market is witnessing significant growth, driven by the increasing prevalence of alcohol-related liver diseases globally. According to the World Health Organization (WHO), alcohol consumption contributes to over 3 million deaths annually, with a considerable portion attributed to alcoholic hepatitis. Additionally, heightened awareness about the severity of alcoholic hepatitis and the importance of early intervention has spurred a greater demand for effective treatments. Governments and healthcare organizations are intensifying efforts to educate the public about the risks associated with excessive alcohol consumption, further propelling market growth. For instance, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in the United States has launched
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis [Yahoo! Finance][Yahoo! Finance]
- Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis[Business Wire]
- Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy[Business Wire]
- ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder [Yahoo! Finance][Yahoo! Finance]
- One stock is dragging down the S&P 500's earnings growth [Yahoo! Finance Canada][Yahoo! Finance Canada]
- More
GILD
SEC Filings
SEC Filings
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- GILD's page on the SEC website
- More